In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo
Proteasome-catalyzed peptide splicing (PCPS) of cancer-driving antigens could generate attractive neoepitopes to be targeted by T cell receptor (TCR)-based adoptive T cell therapy. Based on a spliced peptide prediction algorithm, TCRs were generated against putative KRASG12V- and RAC2P29L-derived ne...
Main Authors: | Gerald Willimsky, Christin Beier, Lena Immisch, George Papafotiou, Vivian Scheuplein, Andrean Goede, Hermann-Georg Holzhütter, Thomas Blankenstein, Peter M Kloetzel |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-04-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/62019 |
Similar Items
-
Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors
by: Lena Immisch, et al.
Published: (2023-02-01) -
Beware the algorithm
by: Peter van Endert
Published: (2021-05-01) -
Corrigendum: Elucidation of the Signatures of Proteasome-Catalysed Peptide Splicing
by: Wayne Paes, et al.
Published: (2021-09-01) -
An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development?
by: Anouk C. M. Platteel, et al.
Published: (2017-11-01) -
Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes
by: Juliane Liepe, et al.
Published: (2015-09-01)